BidaskClub upgraded shares of CME Group (NASDAQ:CME) from a hold rating to a buy rating in a report released on Tuesday morning.

Several other equities research analysts also recently commented on CME. Keefe, Bruyette & Woods reiterated a hold rating and set a $133.00 target price on shares of CME Group in a report on Thursday, September 21st. Wells Fargo & Co raised their target price on CME Group from $130.00 to $145.00 and gave the company a market perform rating in a report on Wednesday, October 4th. Barclays raised their target price on CME Group from $139.00 to $149.00 and gave the company an overweight rating in a report on Tuesday, October 10th. Royal Bank of Canada raised their target price on CME Group from $135.00 to $147.00 and gave the company an outperform rating in a report on Monday, October 16th. Finally, Citigroup raised their target price on CME Group from $138.00 to $155.00 and gave the company a buy rating in a report on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has an average rating of Buy and an average target price of $144.22.

CME Group (NASDAQ CME) traded down $0.08 during trading on Tuesday, hitting $152.73. The stock had a trading volume of 1,108,894 shares, compared to its average volume of 1,148,767. The stock has a market cap of $51,970.00, a P/E ratio of 34.63, a price-to-earnings-growth ratio of 2.55 and a beta of 0.72. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group has a 52 week low of $114.82 and a 52 week high of $155.29.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The company had revenue of $890.80 million for the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the business posted $1.05 EPS. analysts expect that CME Group will post 4.76 EPS for the current fiscal year.

The firm also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th will be paid a dividend of $3.50 per share. The ex-dividend date is Wednesday, December 27th. This is a positive change from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio (DPR) is 59.86%.

In other CME Group news, Director Jeffrey M. Bernacchi sold 1,501 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $149.75, for a total transaction of $224,774.75. Following the completion of the sale, the director now owns 60,194 shares in the company, valued at approximately $9,014,051.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $139.57, for a total value of $362,882.00. Following the sale, the insider now owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,603 shares of company stock valued at $6,250,726. 0.57% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Fiduciary Trust Co. acquired a new position in shares of CME Group in the 2nd quarter worth approximately $105,000. Valeo Financial Advisors LLC acquired a new position in shares of CME Group in the 3rd quarter worth approximately $124,000. Quadrant Capital Group LLC grew its position in shares of CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA acquired a new position in shares of CME Group in the 2nd quarter worth approximately $129,000. Finally, People s United Financial Inc. grew its position in shares of CME Group by 11.5% in the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 82.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “CME Group (CME) Upgraded by BidaskClub to “Buy”” was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://theolympiareport.com/2018/01/12/cme-group-cme-upgraded-by-bidaskclub-to-buy.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with Analyst Ratings Network's FREE daily email newsletter.